The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review

被引：0
|
作者：
Arbabzada, Naik [1 ]
Dennett, Liz [1 ,2 ]
Meng, Guanmin [1 ]
Peerani, Farhad [1 ]
机构：
[1] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada
[2] Univ Alberta, Geoffrey & Robyn Sperber Hlth Sci Lib, Edmonton, AB, Canada
来源：
INFLAMMATORY BOWEL DISEASES | 2024年
关键词：
primary sclerosing cholangitis; inflammatory bowel disease; oral vancomycin; LIVER-TRANSPLANTATION; ULCERATIVE-COLITIS; BILE-ACID; MICROBIOTA; CHILDREN; TRIAL;
D O I：
10.1093/ibd/izae257
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This systematic review summarizes the knowledge on the effectiveness of oral vancomycin in treating inflammatory bowel disease in primary sclerosing cholangitis patients and helps identify knowledge gaps. Ultimately a well-powered randomized controlled trial is required to definitively assess drug efficacy.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    David N. Abarbanel
    Scott M. Seki
    Yinka Davies
    Natalie Marlen
    Joseph A. Benavides
    Kathleen Cox
    Kari C. Nadeau
    Kenneth L. Cox
    Journal of Clinical Immunology, 2013, 33 : 397 - 406
  • [22] Letter to editor: effects of vancomycin in primary sclerosing cholangitis with and without inflammatory bowel disease
    Malik, Sheza
    Loganathan, Priyadarshini
    Mohan, Babu P.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (05) : 630 - 630
  • [23] INFECTIOUS COMPLICATIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Natt, Navneet
    May, Tyrel
    Malhi, Gurpreet
    Dumond, Jennifer
    Tandon, Parul
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S27 - S27
  • [24] INFECTIOUS COMPLICATIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Natt, Navneet
    May, Tyrel
    Malhi, Gurpreet
    Dumond, Jennifer
    Tandon, Parul
    GASTROENTEROLOGY, 2024, 166 (03) : S37 - S37
  • [25] Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
    Torres, J.
    de Chambrun, G. Pineton
    Itzkowitz, S.
    Sachar, D. B.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (05) : 497 - 508
  • [26] Prevalence and phenotype of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Huynh, D.
    Bate, J. P.
    Andrews, J. M.
    Johnson, D.
    Nind, G.
    Harley, Haj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 48 - 48
  • [27] Endoscopic features of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Smith, Timothy
    Swaroop, Prabhakar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S454 - S454
  • [28] The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Lynch K.D.
    Keshav S.
    Chapman R.W.
    Current Hepatology Reports, 2019, 18 (1) : 115 - 126
  • [29] Primary sclerosing cholangitis in Japanese patients: Association with inflammatory bowel disease
    Okada, H
    Mizuno, M
    Yamamoto, K
    Tsuji, T
    ACTA MEDICA OKAYAMA, 1996, 50 (05) : 227 - 235
  • [30] Prevalence and Phenotype of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis
    Huynh, Dep
    Bate, John P.
    Andrews, Jane M.
    Johnson, Richard
    LeMire, Marc
    Nind, Garry
    Harley, Hugh A.
    GASTROENTEROLOGY, 2012, 142 (05) : S991 - S991
12345